VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank71
3Y CAGR-23.0%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-23.0%/yr
vs +49.1%/yr prior
Acceleration
-72.1pp
Decelerating
Percentile
P71
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.02+15.6%
20240.02-91.7%
20230.22+377.9%
20220.05+16.1%
20210.04+105.7%
2020-0.71-7687.0%
20190.01-1.1%
20180.01-91.5%
20170.11+564.6%
2016-0.02-